These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30248673)

  • 1. Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms.
    Baudin E; Hayes AR; Scoazec JY; Filosso PL; Lim E; Kaltsas G; Frilling A; Chen J; Kos-Kudła B; Gorbunova V; Wiedenmann B; Nieveen van Dijkum E; Ćwikła JB; Falkerby J; Valle JW; Kulke MH; Caplin ME; ;
    Neuroendocrinology; 2019; 108(1):7-17. PubMed ID: 30248673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
    Caplin ME; Baudin E; Ferolla P; Filosso P; Garcia-Yuste M; Lim E; Oberg K; Pelosi G; Perren A; Rossi RE; Travis WD;
    Ann Oncol; 2015 Aug; 26(8):1604-20. PubMed ID: 25646366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine tumours--challenges in the diagnosis and classification of pulmonary neuroendocrine tumours.
    den Bakker MA; Thunnissen FB
    J Clin Pathol; 2013 Oct; 66(10):862-9. PubMed ID: 23685279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
    Rouquette Lassalle I
    Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3).
    Sorbye H; Baudin E; Borbath I; Caplin M; Chen J; Cwikla JB; Frilling A; Grossman A; Kaltsas G; Scarpa A; Welin S; Garcia-Carbonero R;
    Neuroendocrinology; 2019; 108(1):54-62. PubMed ID: 30153658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of typical and atypical lung carcinoids.
    Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
    Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head: Should Ki67 proliferation index be included in the formal classification of pulmonary neuroendocrine neoplasms?
    Pelosi G; Travis WD
    Histopathology; 2024 Oct; 85(4):535-548. PubMed ID: 38728050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of
    Bongiovanni A; Recine F; Riva N; Foca F; Liverani C; Mercatali L; Nicolini S; Pieri F; Amadori D; Ibrahim T
    Clin Lung Cancer; 2017 Jul; 18(4):415-420. PubMed ID: 27956089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Neuroendocrine Tumors.
    Borczuk AC
    Surg Pathol Clin; 2020 Mar; 13(1):35-55. PubMed ID: 32005434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and treatment of the neuroendocrine tumors of the lung].
    Gálffy G
    Magy Onkol; 2018 Jul; 62(2):113-118. PubMed ID: 30027939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence.
    Marchevsky AM; Hendifar A; Walts AE
    Mod Pathol; 2018 Oct; 31(10):1523-1531. PubMed ID: 29802361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular pathogenesis and management of bronchial carcinoids.
    Cakir M; Grossman A
    Expert Opin Ther Targets; 2011 Apr; 15(4):457-91. PubMed ID: 21275849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force.
    Koumarianou A; Filosso PL; Bodei L; Castano JP; Fernandez-Cuesta L; Deroose CM; Foll M; Dromain C; Reed NS; Caplin M; Capdevila J; Falkerby J; Faggiano A; Frilling A; Grande E; Hicks RJ; Kasajima A; Kos-Kudla B; Krishna BA; Lim E; Rinke A; Singh S; Thirlwell C; Volante M; Walter T
    J Neuroendocrinol; 2024 Aug; 36(8):e13412. PubMed ID: 38754956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
    Wolin EM
    Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary carcinoid and related tumours.
    Hasleton PS; Bostanci G
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():28-42. PubMed ID: 9337521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives?
    Scoazec JY
    Ann Endocrinol (Paris); 2019 Jun; 80(3):163-165. PubMed ID: 31064659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
    Correia Sda S; Pinto C; Bernardo J
    Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Symptoms and diagnostics of lung neuroendocrine tumors].
    Tamási L; Müller V
    Orv Hetil; 2011 Mar; 152(10):366-70. PubMed ID: 21354952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.